RedHill Biopharma Ltd.: Q3 results did not meet expectations mainly with GI drug sales; financially, capital raising of $20.6M (NIS 1.94 per share) positions Redhill with sufficient funds until 2018. jaimeuss_admin 17 בSeptember 2018 Research 0 Comments Continue Reading
Energix Renewable Energies Ltd.: Completion of stage II connection to the company’s flagship Polish project and successful capital raising are positive indicators. We have raised the price target to NIS 3.82. jaimeuss_admin 6 בSeptember 2018 Research 0 Comments Continue Reading